UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma

Investigational new drugs, 2019-04, Vol.37 (2), p.323-330

2019

Volltextzugriff (PDF)

Diagnosis of Concurrent Pulmonary Tuberculosis and Tuberculous Otitis Media Confirmed by Xpert MTB/RIF in the United States

Infectious diseases in clinical practice (Baltimore, Md.), 2016-05, Vol.24 (3), p.180-182

2016

Volltextzugriff (PDF)

NOD2 status and human ileal gene expression

Inflammatory bowel diseases, 2010-10, Vol.16 (10), p.1649-1657

2010

Volltextzugriff (PDF)

T1556 The Role of Genotype and Phenotype in Patients with Perianal Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-911-A-911

2009

Volltextzugriff (PDF)

S1178 NOD2 Risk Alleles Combined with Habitual Cigarette Smoking Accelerate the Time to Second Ileocolic Resection in Crohn's Disease

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (5), p.A-207-A-207

2009

Volltextzugriff (PDF)

Abstract P202: Initial findings from an ongoing first-in-human phase 1 study of the CBP/p300 inhibitor FT-7051 in men with metastatic castration-resistant prostate cancer

Molecular cancer therapeutics, 2021-12, Vol.20 (12_Supplement), p.P202-P202

2021

Volltextzugriff (PDF)

Use of Bone-Modifying Agents in Myeloma and Bone Metastases: How Recent Dosing Interval Studies Have Affected Our Practice

Journal of oncology practice, 2018-08, Vol.14 (8), p.457-464

2018

Volltextzugriff (PDF)

Abstract 547: Urine tumor DNA MRD detection and correlation with pathologic complete response in muscle-invasive bladder cancer treated with curative-intent radical cystectomy

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.547-547

2021

Volltextzugriff (PDF)

Abstract 965: Urine cell-free DNA multi-omics combining copy number analysis with fragmentomics to detect minimal residual disease in bladder cancer patients

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.965-965

2024

Volltextzugriff (PDF)

Deep Sequencing to Detect Diversity of Trypanosoma cruzi Infection in Patients Coinfected With Human Immunodeficiency Virus and Chagas Disease

The Journal of infectious diseases, 2022-01, Vol.225 (2), p.243-247

2022

Volltextzugriff (PDF)

Abstract CT119: A first-in-human phase 1 study of LOXO-435, a potent, highly isoform-selective FGFR3 inhibitor in advanced solid tumors with FGFR3 alterations (trial in progress)

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT119-CT119

2023

Volltextzugriff (PDF)

Abstract 2219: Urine cell-free DNA multi-omics to detect molecular residual disease and predict survival in bladder cancer patients

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.2219-2219

2023

Volltextzugriff (PDF)

Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma

Clinical genitourinary cancer, 2020, Vol.18 (5), p.361-366

2020

Volltextzugriff (PDF)

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance

Nature communications, 2022-11, Vol.13 (1), p.6929-21, Article 6929

2022

Volltextzugriff (PDF)

Molecular and cellular reorganization of neural circuits in the human lineage

Science (American Association for the Advancement of Science), 2017-11, Vol.358 (6366), p.1027-1032

2017

Volltextzugriff (PDF)

A phase 1b clinical trial of cabozantinib (CABO) and abiraterone (ABI) with checkpoint inhibitor immunotherapy (CPI) in metastatic hormone-sensitive prostate cancer (mHSPC) (CABIOS Trial)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.TPS214-TPS214

2022

Volltextzugriff (PDF)

CABIOS trial: A phase Ib study of cabozantinib and nivolumab in combination with abiraterone in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5084-5084

2023

Volltextzugriff (PDF)

Abstract 15754: Coronary Calcification is Associated With Prior GnRH Agonist Therapy in Men With Recurrent Prostate Cancer Undergoing PET/CT Imaging

Circulation (New York, N.Y.), 2020-11, Vol.142 (Suppl_3 Suppl 3), p.A15754-A15754

2020

Volltextzugriff (PDF)

A phase 1/2, open-label, multicenter, dose escalation and cohort expansion study of the safety and efficacy of anti-CD70 allogeneic CRISPR-Cas9–engineered T cells (CTX131) in adult patients with relapsed or refractory solid tumors

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.TPS2676-TPS2676

2024

Volltextzugriff (PDF)

Phase 1b study of tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTEimmune therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate cancer (NEPC)

Journal of clinical oncology, 2022-02, Vol.40 (6_suppl), p.TPS197-TPS197

2022

Volltextzugriff (PDF)

A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.387-387

2023

Volltextzugriff (PDF)

An emerging mycoplasma associated with trichomoniasis, vaginal infection and disease

PloS one, 2014-10, Vol.9 (10), p.e110943-e110943

2014

Volltextzugriff (PDF)

Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.5032-5032

2021

Volltextzugriff (PDF)

The Courage study: A first-in-human phase 1 study of the CBP/p300 inhibitor FT-7051 in men with metastatic castration-resistant prostate cancer

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.TPS5085-TPS5085

2021

Volltextzugriff (PDF)

A pilot trial of neoantigen DNA vaccine in combination with nivolumab/ipilimumab and prostvac in metastatic hormone-sensitive prostate cancer (mHSPC)

Journal of clinical oncology, 2021-02, Vol.39 (6_suppl), p.TPS192-TPS192

2021

Volltextzugriff (PDF)

26 – 50 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(70)
Berichte
(1)
Reviews
(1)

Sprache

Englisch
(72)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pazopanib with low fat meal (PALM) in advanced renal cell carcinoma

Diagnosis of Concurrent Pulmonary Tuberculosis and Tuberculous Otitis Media Confirmed by Xpert MTB/RIF in the United States

NOD2 status and human ileal gene expression

T1556 The Role of Genotype and Phenotype in Patients with Perianal Crohn's Disease

S1178 NOD2 Risk Alleles Combined with Habitual Cigarette Smoking Accelerate the Time to Second Ileocolic Resection in Crohn's Disease

Abstract P202: Initial findings from an ongoing first-in-human phase 1 study of the CBP/p300 inhibitor FT-7051 in men with metastatic castration-resistant prostate cancer

Use of Bone-Modifying Agents in Myeloma and Bone Metastases: How Recent Dosing Interval Studies Have Affected Our Practice

Abstract 547: Urine tumor DNA MRD detection and correlation with pathologic complete response in muscle-invasive bladder cancer treated with curative-intent radical cystectomy

Abstract 965: Urine cell-free DNA multi-omics combining copy number analysis with fragmentomics to detect minimal residual disease in bladder cancer patients

Deep Sequencing to Detect Diversity of Trypanosoma cruzi Infection in Patients Coinfected With Human Immunodeficiency Virus and Chagas Disease

Abstract CT119: A first-in-human phase 1 study of LOXO-435, a potent, highly isoform-selective FGFR3 inhibitor in advanced solid tumors with FGFR3 alterations (trial in progress)

Abstract 2219: Urine cell-free DNA multi-omics to detect molecular residual disease and predict survival in bladder cancer patients

Elective Cytoreductive Nephrectomy After Checkpoint Inhibitor Immunotherapy in Patients With Initially Unresectable Metastatic Clear Cell Renal Cell Carcinoma

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance

Molecular and cellular reorganization of neural circuits in the human lineage

A phase 1b clinical trial of cabozantinib (CABO) and abiraterone (ABI) with checkpoint inhibitor immunotherapy (CPI) in metastatic hormone-sensitive prostate cancer (mHSPC) (CABIOS Trial)

CABIOS trial: A phase Ib study of cabozantinib and nivolumab in combination with abiraterone in patients (pts) with metastatic hormone sensitive prostate cancer (mHSPC)

Abstract 15754: Coronary Calcification is Associated With Prior GnRH Agonist Therapy in Men With Recurrent Prostate Cancer Undergoing PET/CT Imaging

A phase 1/2, open-label, multicenter, dose escalation and cohort expansion study of the safety and efficacy of anti-CD70 allogeneic CRISPR-Cas9–engineered T cells (CTX131) in adult patients with relapsed or refractory solid tumors

Phase 1b study of tarlatamab, a half-life extended bispecific T-cell engager (HLE BiTEimmune therapy) targeting DLL3, in de novo or treatment emergent neuroendocrine prostate cancer (NEPC)

A phase 2 study of ibrutinib as neoadjuvant therapy in patients with localized prostate cancer

An emerging mycoplasma associated with trichomoniasis, vaginal infection and disease

Survival of veterans treated with enzalutamide and abiraterone in advanced prostate cancer

The Courage study: A first-in-human phase 1 study of the CBP/p300 inhibitor FT-7051 in men with metastatic castration-resistant prostate cancer

A pilot trial of neoantigen DNA vaccine in combination with nivolumab/ipilimumab and prostvac in metastatic hormone-sensitive prostate cancer (mHSPC)

Suchergebnisse filtern